Regenyx Medical
Regenyx is redefining soft tissue restoration with matrix-enhanced fat grafting
StartupRegenyx Medical is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2016. Regenyx is redefining soft tissue restoration with matrix-enhanced fat grafting. The company has raised a total of $3.4M across 3 funding rounds, currently at the Seed stage. Regenyx Medical was founded by Yaron Rapaport and Prof. Hanna Rapaport. Key investors include Israel Innovation Authority, Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Materials & Substances.
With $3.4M in total funding, Regenyx Medical is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last Round$1.4M
- Israel Innovation AuthorityLead
- Undisclosed Investor(s)Lead
Yaron RapaportFounder & CEO
Prof. Hanna RapaportFounder, Inventor & CSO
4 articles covered by sources including www.plasticsurgery.org,
medtechinnovator.org,
in.bgu.ac.il,
www.timesofisrael.com.
What does Regenyx Medical do?
Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery. Our lead product, Lipogenyx, is the first fat viability extender: a next-generation fat grafting solution that enhances graft survival and integration, enabling natural-looking, lasting and predictable results in reconstructive and aesthetic procedures. Built on a proprietary synthetic peptide hydrogel technology, Lipogenyx offers a scalable, potentially reimbursable platform that eliminates the need to revision fat grafting procedures and streamlines physicians efficiency and patient satisfaction. Selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track, Regenyx is now preparing for its first clinical study and establishing U.S. operations.
How much funding has Regenyx Medical raised?
Regenyx Medical has raised $3.4M in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include Israel Innovation Authority, Undisclosed Investor(s).
Who founded Regenyx Medical?
Regenyx Medical was founded in 2016 by Yaron Rapaport (Founder & CEO), Prof. Hanna Rapaport (Founder, Inventor & CSO).
What sector is Regenyx Medical in?
Regenyx Medical operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, Drug Delivery, with core technologies in Materials & Substances. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Life Sciences.
Where is Regenyx Medical located?
Regenyx Medical is based in Prof. A. D. Bergman St 2, Rehovot, Israel, Center District.